Compare LSE & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSE | ZTEK |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 68.8M |
| IPO Year | N/A | 2022 |
| Metric | LSE | ZTEK |
|---|---|---|
| Price | $5.17 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.6K | ★ 96.9K |
| Earning Date | 01-30-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $61.76 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.80 | $0.46 |
| 52 Week High | $9.78 | $1.84 |
| Indicator | LSE | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 30.72 |
| Support Level | $5.13 | N/A |
| Resistance Level | $5.70 | $0.57 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 59.35 | 16.71 |
Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.